Haipeng Xu

Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell l...

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as eerstelijns treatment for gevorderd squamous n...